Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
/in Dendritic Cells, International Publications, Prostate Cancer /von 1996-12-01 / Prostate 1996 Dec;29(6):371-80Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 1993-01-01 / Virchows Arch A Pathol Anat Histopathol 1993;422(5):351-5[Distribution of S-100 protein-positive dendritic cells in transitional cell carcinoma of human bladder and its relation to clinical prognosis]
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 1991-10-01 / Zhonghua Yi Xue Za Zhi 1991 Oct;71(10):579-80, 40IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de